Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia

Pharmacopsychiatry

Volumn 29, Issue 5, 1996, Pages 187-192

  Hajak, G ^a   Rodenbeck, A ^a   Adler, L ^a   Huether, G ^a   Bandelow, B ^a   Herrendorf, G ^a   Staedt, J ^a   Ruther E ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXEPIN; MELATONIN; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INSOMNIA; MALE; ORAL DRUG ADMINISTRATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP;

EID: 0029811453     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979569     Document Type: Article

References (39)

1. American Psychiatrie Association: Diagnostic and statistical manual of mental disorders. 4th ed. DSM-IV, Washington/DC, 1994
2. American Sleep Disorders Association (ASDA): The International classification of sleep disorders: diagnostic and coding manual. Allen, Lawrence, 1990
3. Aschoff, J.: Handbook of behavioural neurobiology. Biol. Rhythms, Vol. 4, Plenum, New York, 1981
4. Aschoff, J., R. Wever: The circadian system. In: Aschoff, J. (ed.): Biological rhythms: handbook of behavioural neurobiology, Vol. 4, Plenum, New York (1981) p. 311-331
5. Benca, R. M., W. H. Obermeyer, R. A. Thisted, J. C. Gillin: Sleep and psychiatric disorders: a meta-analysis. Arch. Gen. Psychiat. 49 (1992) 651-668
6. Benca, R. M.: The affective disorders. In: Cooper, R. (ed.): Sleep. Chapman & Hall Medical, London (1994) 525-556
7. Checkley, S. A., E. Palazidou: Melatonin and antidepressant drugs: clinical pharmacology. In: Miles, A., D. R. S. Philbrick, C. Thompson (eds.): Melatonin, clinical perspectives. Oxford University, New York (1988) 190-204
8. Copinschi, G., E. Akseki, R. Moreno-Reyes, R. Leproult, M. L'Hermite-Balériaux, A. Caufriez, F. Vertongen, E. Van Cauter: Effects of bedtime administration of Zolpidem on circadian and sleep-related hormonal profiles in normal women. Sleep 18 (1995) 417-427
9. Copinschi, G., A. Van Onderbergen, M. L'Hermite-Balériaux et al.: Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. Sleep 13 (1990) 232-244
10. Cowen, P. J., A. R. Green, D. G. Graham Smith, L. E. Braddock: Plasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic transmission. Br. J. Clin. Pharmacol. 19 (1985) 799-805
11. Demisch, K., L. Demisch, T. Nickeisen, R. Rieth: The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects. J. Neural. Transm. 68 (1987) 257-270
12. Demisch, L., T. Silaff, H. P. Gerbaldo, P. Gebhart: Abschwächung der Fluvoxamin-stimulierten Melatoninsekretion bei depressiven Patienten nach einer erfolgreichen Amitriptylin-Behandlung. Fort. Neurol. Psychiat. 1 (1990) 21
13. Franey, C., M. Alhous, S. Burton, S. A. Checkley, J. Arendt: Acute treatment with desipramine stimulates melatonin and 6-sulphatoxymelatonin secretion in man. Br. J. Clin. Pharmacol. 22 (1986) 73-79
14. Fraser, S., P. Cowen, M. Franklin, C. Franey, J. Arendt: Direct radioimmunoassay for melatonin in plasma. Clin. Chem. 29 (1983) 396-397
15. Golden, R. N., H. R. Miller, R. B. Lydiard, G. Mason: The effects of antidepressant treatment on noradrenergic function. Biol. Psychiatry 29 (1991) 128A-129A
16. Haimov, I., A. Schlitner, O. Tzischinsky, A. Sadeh, N. Zisapel, M. Louden, P. Lavie: Circadian melatonin levels in the elderly: relation to sleep disorders and light exposure. 6th Colloquium of the European Pineal Society, Copenhagen, July 23-27, 1993, Abstract book
17. Hajak, G., A. Rodenbeck, B. Bandelow, S. Friedrichs, G. Hüther, E. Rüther: Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects. Eur. Neuropsychopharmacol. (in press)
18. Hajak, G., A. Rodenbeck, J. Staedt, B. Bandelow, G. Hüther, E. Rüther: Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia. J. Pineal Res. 19 (1995) 116-122
19. Hansen, T., T. Bratlid, O. Lingjärde, T. Brenn: Midwinter insomnia in the subarctic region: evening levels of serum melatonin and cortisol before and after treatment with bright artificial light. Acta Psychiat. Scand. 75 (1987) 428-434
20. Hohagen, F., R. Fritsch Montero, E. Weiss, S. Lis, E. Schönbrunn, H. Dressing, D. Riemann, M. Berger: Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics? Eur. Arch. Psychiat. Clin. Neurosci. 244 (1994) 65-72
21. Kabuto, M., I. Namura, Y. Saitoh: Nocturnal enhancement of plasma melatonin could be suppressed by benzodiazepines in humans. Endocrinol. Japan 33 (1986) 405-414
22. Kennedy, S. H., G. M. Brown: Effects of chronic antidepressant treatment with adinazolam and desipramine on melatonin output. Psychiat. Res. 43 (1992) 177-185
23. Kupfer, D. J., B. L. Weiss, D. P. Detre, F. G. Foster: First night effect revisited: a clinical note. J. Nerv. Ment. Dis. 159 (1974) 205-209
24. Lack, L., R. Kalucy, R. Balfour: Insomniacs have less decrease in body temperature following sleep onset. Sleep Res. 17 (1988) 209
25. Lewy, A. J., R. L. Sack: The dim light melatonin onset as a marker for circadian phase position. Chronobiol. Int. 6 (1989) 93-102
26. MacFarlane, J. G., J. M. Cleghorn, G. M. Brown: Melatonin and core temperature rhythm in chronic insomnia. Adv. Biosci. 53 (1984a) 301-306
27. MacFarlane, J. G., J. M. Cleghorn, G. M. Brown, R. Kaplan, P. J. Brown, J. Mitton: Circadian rhythms in chronic insomnia. Sleep Res. 13 (1984b) 223
28. McIntyre, I. M., G. D. Burrows, T. R. Norman: Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans. Biol. Psychiatry 24 (1988) 105-108
29. McIntyre, I. M., T. R. Norman, G. D. Burrows, S. M. Armstrong: Alterations to plasma melatonin and cortisol after evening alprazolam administration in humans. Chronobiol. Int. 10 (1993) 205-213
30. Monteleone, P., D. Forziati, C. Orazzo, M. Maj: Preliminary observations on the suppression of nocturnal plasma melatonin levels by short term administration of diazepam in humans. J. Pineal Res. 6 (1989) 253-258
31. Palazidou, E., A. Papadopoulos, H. Ratcliff, S. Dawling, S. A. Checkley: Noradrenaline uptake inhibition increases melatonin secretion, a measure of noradrenergic neurotransmission, in depressed patients. Psychol. Med. 22 (1992) 309-315
32. Pecknold, J. C., L. Luthe: Trimipramine, anxiety, depression and sleep. Drugs 38 (Suppl. 1) (1989) 25-31
33. Penzel, T., G. Hajak, R. M. Hoffmann, R. Lund, T. Pollmächer, T. Schäfer, H. Schneider, H. Schulz, W. Sonnenschein, I. Spieweg: Empfehlungen zur Durchführung und Auswertung polysomnographischer Ableitungen im diagnostischen Schlaflabor. Z. EEG-EMG 24 (1993) 65-70
34. Rechtschaffen, A., A. Kales: A manual for standard terminology, techniques and scoring system for sleep stages of human subjects. Public Health Service, US Government, Printing Office, Washington DC, 1968
35. Riemann, D., M. Schnitzler, F. Hohagen, M. Berger: Depression and sleep - present state of research. Fortschr. Neurol. Psychiat. 62 (1994) 458-478
36. Rosenthal, N. E.: Plasma melatonin as a measure of the human clock (ed.). J. Clin. Endocrin. Metab. 73 (1991) 225-226
37. Schramm, E., F. Hohagen, U. Grasshoff, D. Riemann, G. Hajak, H. G. Weess, M. Berger: Test-retest reliability and validity of a structured interview for sleep disorders according to DSM-III-R. Am. J. Psychiat. 150 (1993) 867-872
38. Simen, S., G. Hajak, G. Schlaf, J. Westenhöfer, A. Rodenbeck, B. Bandelow, V. Pudel, E. Rüther: Chronification of sleep complaints - results from a representative survey in West Germany. Nervenarzt 66 (1995) 686-695
39. Wiegend, M., M. Berger: Action of trimipramine on sleep and pituitary hormone secretion. Drugs 38 (Suppl. 1) (1989) 35-42